Related Experiment Videos
Long-term consequences of deep vein thrombosis
1Clinical Pharmacology Unit, Hôpital Cardio-Vasculaire et Pneumologique Louis Pradel, Lyon, France.
Haemostasis
|March 9, 1999
Summary
Deep vein thrombosis (DVT) patients face long-term risks of recurrence, post-thrombotic syndrome, and death despite effective treatments. Ongoing research aims to optimize long-term therapeutic strategies for these venous thromboembolism (VTE) complications.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Vascular Surgery
Background:
- Deep vein thrombosis (DVT) and venous thromboembolism (VTE) pose significant long-term health risks.
- Key complications include VTE recurrence, post-thrombotic syndrome, and mortality.
- Antithrombotic therapy reduces VTE recurrence but increases bleeding risk.
Purpose of the Study:
- To review the long-term prognosis and complications following an acute DVT event.
- To highlight the persistent risks of death, VTE recurrence, and post-thrombotic syndrome.
- To identify the need for optimized therapeutic strategies for prolonged treatment.
Main Methods:
- Review of long-term follow-up studies on DVT patients.
- Analysis of complication rates including VTE recurrence, post-thrombotic syndrome, and mortality.
- Evaluation of current treatment effectiveness and limitations.
Main Results:
- Early VTE recurrence risk (3 months) is 3-6% with anticoagulant treatment.
- Long-term VTE recurrence risk persists over several years.
- Post-thrombotic syndrome affects a significant portion of patients, with ulceration in 2-10% at 10 years.
Conclusions:
- Despite advances, significant risks of death, VTE recurrence, and post-thrombotic syndrome persist years after acute VTE.
- Current therapeutic strategies require further development for optimal long-term management.
- Future research should focus on identifying optimal regimens for prolonged anticoagulation.